BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27485839)

  • 1. The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.
    Reales-Calderón JA; Molero G; Gil C; Martínez JL
    Future Med Chem; 2016 Aug; 8(12):1503-20. PubMed ID: 27485839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and synthetic peptides with antifungal activity.
    Ciociola T; Giovati L; Conti S; Magliani W; Santinoli C; Polonelli L
    Future Med Chem; 2016 Aug; 8(12):1413-33. PubMed ID: 27502155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal Biofilms: Update on Resistance.
    Borghi E; Borgo F; Morace G
    Adv Exp Med Biol; 2016; 931():37-47. PubMed ID: 27115411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
    Delarze E; Sanglard D
    Drug Resist Updat; 2015 Nov; 23():12-19. PubMed ID: 26690338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
    Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
    Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genesis of Azole Antifungal Resistance from Agriculture to Clinical Settings.
    Azevedo MM; Faria-Ramos I; Cruz LC; Pina-Vaz C; Rodrigues AG
    J Agric Food Chem; 2015 Sep; 63(34):7463-8. PubMed ID: 26289797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative treatment of fungal infections: Synergy with non-antifungal agents.
    Rossato L; Camargo Dos Santos M; Vitale RG; de Hoog S; Ishida K
    Mycoses; 2021 Mar; 64(3):232-244. PubMed ID: 33098146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal drug resistance: evolution, mechanisms and impact.
    Revie NM; Iyer KR; Robbins N; Cowen LE
    Curr Opin Microbiol; 2018 Oct; 45():70-76. PubMed ID: 29547801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of fungal resistance: an overview.
    Balkis MM; Leidich SD; Mukherjee PK; Ghannoum MA
    Drugs; 2002; 62(7):1025-40. PubMed ID: 11985489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal adjuvants: Preserving and extending the antifungal arsenal.
    Butts A; Palmer GE; Rogers PD
    Virulence; 2017 Feb; 8(2):198-210. PubMed ID: 27459018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tackling Fungal Resistance by Biofilm Inhibitors.
    Wu S; Wang Y; Liu N; Dong G; Sheng C
    J Med Chem; 2017 Mar; 60(6):2193-2211. PubMed ID: 28051303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids as targets for treatment of fungal infections.
    Rollin-Pinheiro R; Singh A; Barreto-Bergter E; Del Poeta M
    Future Med Chem; 2016 Aug; 8(12):1469-84. PubMed ID: 27502288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?
    Hull CM; Purdy NJ; Moody SC
    Future Microbiol; 2014; 9(3):307-25. PubMed ID: 24762306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medically important fungi respond to azole drugs: an update.
    Zavrel M; White TC
    Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteroresistance and fungi.
    Ferreira GF; Santos DA
    Mycoses; 2017 Sep; 60(9):562-568. PubMed ID: 28660647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi.
    Hokken MWJ; Zwaan BJ; Melchers WJG; Verweij PE
    Fungal Genet Biol; 2019 Nov; 132():103254. PubMed ID: 31326470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
    Hof H
    Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.